Features & Compatibility
Semaglutide is a GLP-1 analogue and GLP-1 receptor agonist that selectively binds to and activates GLP-1 receptors. It is widely used in laboratory research involving glucose metabolism, insulin signaling, appetite regulation, energy balance, and other related metabolic mechanisms.
Its selective receptor activity makes Semaglutide a useful reference compound for studying GLP-1–mediated biological pathways in controlled research environments. FDA reference
Variants:
5mg10vials | 15mg10vials | 20mg10vials | 30mg10vials | 40mg10vials | 50mg10vials
For laboratory research use only. Not intended for human consumption or therapeutic use.
Customer Reviews
Related Products
BPC+TB500
This research blend combines BPC-157 and TB-500, two peptides investigated in laboratory models involving cellular repair and tissue-response mechanisms. BPC-157
Eloralintide
Eloralintide, formerly known as LY3841136, is an investigational, long-acting and selective amylin receptor agonist. It is designed to mimic amylin,
Glow
Glow is a three-component research peptide blend combining BPC-157, GHK-Cu and TB-500. The formula is designed for laboratory studies involving
Klow80
Klow is a four-component research peptide blend combining GHK-Cu, TB-500, BPC-157 and KPV. The formula is designed for laboratory research
LYSINE-PROLINE-VALINE(KPV)
KPV is a short tripeptide composed of Lysine, Proline and Valine. It represents the C-terminal amino-acid sequence of alpha-melanocyte-stimulating hormone
Semax
Semax is a synthetic heptapeptide composed of an ACTH (4–7) fragment combined with the Pro-Gly-Pro (PGP) sequence. It is studied

Reviews
There are no reviews yet.